A NEW BACTERIAL TRANSFER THERAPY FOR IBD: ENDOSCOPIC BIFIDOBACTERIUM AND XYLOGLUCAN ADMINISTRATION
| Autor: | Huseyin Sancar Bozkurt |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Hepatology biology business.industry Gastroenterology Mucous membrane medicine.disease biology.organism_classification Ulcerative colitis Inflammatory bowel disease Single dose regimen Xyloglucan chemistry.chemical_compound medicine.anatomical_structure chemistry Internal medicine medicine Colonic mucous membrane Immunology and Allergy business Irritable bowel syndrome Bifidobacterium |
| Zdroj: | Inflammatory Bowel Diseases. 27:S37-S38 |
| ISSN: | 1536-4844 1078-0998 |
| DOI: | 10.1093/ibd/izaa347.091 |
| Popis: | Ulcerative colitis (UC) pathogenesis includes the altered gut microbiota, environmental factors, and human immune and genetic predisposition. Recently, its association with reduced bifidobacteria quantity in the microbiota is reported.Xyloglucan, a plant based prebiotic oligosaccharide, causes increase in bifidobacteria quantity. In this article we share the results of our UC cases treated by intracolonic single dose administration of Bifidobacterium animalis subsp. Lactis and xyloglucan combination. Intracolonic single dose administration of 200 billion CFUs of Bifidobacterium animalis subsp. lactis and 4 gr of xyloglucan combination was administrated to ten severe UC patients, who were either unresponsive or had inadequate response to treatment. All patients continued treatment after the procedure. Treatment responses were evaluated by colonoscopic, laboratory and clinical examination after 6 weeks. Intracolonic single dose administration of Bifidobacterium animalis subsp. lactis and xyloglucan was found effective in the mucosal healing and resolution of colonic symptoms in ulcerative colitis patients. Intracolonic administration of Bifidobacterium animalis subsp. lactis and xyloglucan in UC is a new single strain and strain specific prebiotic combination method. It is easy to apply and has no observable side effect. Its effectiveness on mucosal healing could be attributed to the enhancement of non-stimulatory status and biodiversity in colonic mucosa. Nonetheless, it is still necessary to develop diagnostic strategies to determine the patients to whom this method would be the most applicable. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|